Search research articles
Contact Us
Filters
Showing results (261-270 of 940) with videos related to
Page
of 94
Sort By:
British Journal of Cancer
|
October 22, 2009
Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells
T Terakawa, H Miyake, J Furukawa, et al.
Physiotherapy
|
November 20, 2024
Explorations of strategies for inclusion for newly qualified physiotherapists from racially minoritised groups in a large, urban NHS Trust, UK
C Turner, T Bhandari, G D Jones, et al.
Translational Andrology and Urology
|
June 10, 2024
Rucaparib monotherapy in the heavily pre-treated metastatic castrate-resistant prostate cancer setting: practical considerations and alternate treatment approaches
Rashid K Sayyid, Rui Bernardino, Julian Chavarriaga, et al.
Annals of the Royal College of Surgeons of England
|
May 1, 1979
Abnormal liver function during nutritional support in postoperative cancer patients
F D Skidmore, D E Tweedle, E N Gleave, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
June 18, 2015
A Novel Triazole Nucleoside Suppresses Prostate Cancer Cell Growth by Inhibiting Heat Shock Factor 1 and Androgen Receptor
Yi Xia, Menghua Wang, Eliana Beraldi, et al.
Urology
|
September 19, 2006
Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy
Hideaki Miyake, Mototsugu Muramaki, Toshifumi Kurahashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model
M Gleave, A Tolcher, H Miyake, et al.
Neoplasia (New York, N.Y.)
|
September 26, 2001
Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin
T Zellweger, H Miyake, L V July, et al.
The Prostate. Supplement
|
January 1, 1996
Control of tumor progression by maintenance of apoptosis
N Bruchovsky, R Snoek, P S Rennie, et al.
The Prostate
|
April 6, 2004
Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter
Duan Yu, William W Jia, Martin E Gleave, et al.
Page
of 94
Search research articles
Search
Showing results (261-270 of 940) with videos related to
Sort By:
Page
of 94
British Journal of Cancer
|
October 22, 2009
Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells
T Terakawa, H Miyake, J Furukawa, et al.
Physiotherapy
|
November 20, 2024
Explorations of strategies for inclusion for newly qualified physiotherapists from racially minoritised groups in a large, urban NHS Trust, UK
C Turner, T Bhandari, G D Jones, et al.
Translational Andrology and Urology
|
June 10, 2024
Rucaparib monotherapy in the heavily pre-treated metastatic castrate-resistant prostate cancer setting: practical considerations and alternate treatment approaches
Rashid K Sayyid, Rui Bernardino, Julian Chavarriaga, et al.
Annals of the Royal College of Surgeons of England
|
May 1, 1979
Abnormal liver function during nutritional support in postoperative cancer patients
F D Skidmore, D E Tweedle, E N Gleave, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
June 18, 2015
A Novel Triazole Nucleoside Suppresses Prostate Cancer Cell Growth by Inhibiting Heat Shock Factor 1 and Androgen Receptor
Yi Xia, Menghua Wang, Eliana Beraldi, et al.
Urology
|
September 19, 2006
Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy
Hideaki Miyake, Mototsugu Muramaki, Toshifumi Kurahashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 28, 1999
Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model
M Gleave, A Tolcher, H Miyake, et al.
Neoplasia (New York, N.Y.)
|
September 26, 2001
Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin
T Zellweger, H Miyake, L V July, et al.
The Prostate. Supplement
|
January 1, 1996
Control of tumor progression by maintenance of apoptosis
N Bruchovsky, R Snoek, P S Rennie, et al.
The Prostate
|
April 6, 2004
Prostate-tumor targeting of gene expression by lentiviral vectors containing elements of the probasin promoter
Duan Yu, William W Jia, Martin E Gleave, et al.
Page
of 94